rasagiline

Generic: rasagiline

Labeler: ascend laboratories, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rasagiline
Generic Name rasagiline
Labeler ascend laboratories, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

rasagiline mesylate .5 mg/1

Manufacturer
Ascend Laboratories, LLC

Identifiers & Regulatory

Product NDC 67877-259
Product ID 67877-259_f8b285b7-ed55-4260-bbc7-ebfdff15f6c9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA201889
Listing Expiration 2026-12-31
Marketing Start 2017-10-30

Pharmacologic Class

Classes
monoamine oxidase inhibitor [epc] monoamine oxidase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 67877259
Hyphenated Format 67877-259

Supplemental Identifiers

RxCUI
608328 636664
UPC
0367877260303 0367877259307
UNII
LH8C2JI290

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rasagiline (source: ndc)
Generic Name rasagiline (source: ndc)
Application Number ANDA201889 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .5 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (67877-259-30)
source: ndc

Packages (1)

67877-259-30 30 TABLET in 1 BOTTLE (67877-259-30)

Ingredients (1)

rasagiline mesylate (.5 mg/1)

Linked Drug Pages (1)

Rasagiline ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f8b285b7-ed55-4260-bbc7-ebfdff15f6c9", "openfda": {"upc": ["0367877260303", "0367877259307"], "unii": ["LH8C2JI290"], "rxcui": ["608328", "636664"], "spl_set_id": ["5dfeec8f-f4f3-4e06-915e-3244467516a6"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (67877-259-30)", "package_ndc": "67877-259-30", "marketing_start_date": "20171030"}], "brand_name": "Rasagiline", "product_id": "67877-259_f8b285b7-ed55-4260-bbc7-ebfdff15f6c9", "dosage_form": "TABLET", "pharm_class": ["Monoamine Oxidase Inhibitor [EPC]", "Monoamine Oxidase Inhibitors [MoA]"], "product_ndc": "67877-259", "generic_name": "Rasagiline", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rasagiline", "active_ingredients": [{"name": "RASAGILINE MESYLATE", "strength": ".5 mg/1"}], "application_number": "ANDA201889", "marketing_category": "ANDA", "marketing_start_date": "20171030", "listing_expiration_date": "20261231"}